Musculoskeletal & Regenerative Medicine Practice, Colorado Springs Outpatient Specialty Clinic

$1.6M

Revenue

$1.0M

SDE

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is an outpatient specialty medical practice in Colorado Springs focused on the non-surgical diagnosis and treatment of spine, joint, and musculoskeletal conditions. The revenue model is a deliberate three-legged stool: insurance-based interventional procedures, cash-pay regenerative medicine treatments, and medical-legal services. That mix matters because it blends the stability and payer diversification of insurance work with the higher-margin, faster-collecting economics of cash-pay regenerative treatments, plus the counter-cyclical demand of medical-legal case work.

The practice generates roughly $1.59M in revenue and $1.04M in cash flow, which is a striking 66 percent owner-earnings margin. That level of profitability signals either a lean overhead structure, a physician-owner personally producing a large share of the clinical revenue, or both. The listing emphasizes a loyal patient base, an established referral network, experienced staff, and efficient operational systems, all of which point to a mature going concern rather than a startup.

Positioned in a fast-growing Front Range community with strong demand for musculoskeletal and pain-management care, the practice is pitched as a platform for adding providers, expanding services, and extending geographic reach. The natural buyer is a physician-operator, a healthcare group rolling up specialty clinics, or a strategic buyer who can plug this into a larger interventional or regenerative medicine footprint.

Why we like it

The earnings quality is exceptional on paper: $1.04M of cash flow on $1.59M of revenue is a 66 percent margin, far above typical outpatient specialty comps. The obvious question is how much of that flows through a single owner-physician's clinical labor, but even after normalizing for a replacement physician salary this is a high-margin operation.
The revenue is diversified across three uncorrelated streams: insurance interventional procedures, cash-pay regenerative treatments, and medical-legal services. That diversification cushions against payer reimbursement cuts, regenerative-medicine regulatory shifts, or slowdowns in personal-injury case volume, so no single channel can sink the practice.
Musculoskeletal and pain-management demand is structurally durable and aging-population driven. Spine and joint conditions do not disappear in a recession, and the non-surgical, interventional focus positions the practice at the sweet spot between conservative care and expensive surgery that payers and patients both prefer.
There is a real operator advantage here for a physician-buyer or a regenerative medicine group. An established referral base, trained staff, and working operational systems mean a qualified buyer inherits patient flow on day one and can layer in additional providers rather than building demand from scratch.

How to improve it

Quantify and de-risk owner dependency immediately. Map exactly how much revenue is produced by the owner-physician personally versus mid-level providers and referrals, then recruit or contract a second interventional provider so cash flow survives the seller's exit.
Push the cash-pay regenerative mix. Cash treatments collect faster, carry higher margins, and dodge reimbursement risk, so build a structured consultation-to-treatment funnel and package pricing to grow the highest-margin segment of the book.
Systematize the referral engine. If referrals come from a handful of primary care and orthopedic sources, formalize outreach, track referral sources in the EMR, and add a dedicated liaison so the pipeline is a documented asset rather than personal relationships that walk out with the seller.
Expand geographic reach with a satellite location. The listing flags a rapidly growing Front Range market, so a second clinic or an ancillary site staffed by an added provider can leverage existing branding and back-office systems for incremental volume.
Optimize the medical-legal line. Personal-injury and med-legal work can be lucrative but slow-paying, so tighten documentation standards, build attorney relationships, and manage receivables aggressively to convert that revenue into faster cash.
Audit payer contracts and coding. In a high-margin interventional practice, small improvements in reimbursement capture and clean coding compound quickly, so bring in a specialty billing review to recover leakage and reduce denials.
Add adjacent ancillary services. Physical therapy, imaging, or durable medical equipment can be captured in-house rather than referred out, keeping more of the care episode and revenue inside the practice.

Diligence notes

The single most important item is provider dependency. Determine what share of the $1.04M cash flow depends on the selling physician's personal production and licensure, then normalize for the market-rate salary of a replacement, because the real transferable earnings may be materially lower than the headline number.
Break down revenue by the three streams over at least three years. Insurance interventional, cash-pay regenerative, and medical-legal each carry different collection timelines, margin profiles, and regulatory risk, so understand the trend and concentration of each before pricing the deal.
Scrutinize the regenerative medicine line for regulatory exposure. Stem cell, PRP, and similar cash treatments face evolving FDA and state scrutiny, so verify the specific protocols used, marketing claims made, and whether any treatments carry compliance or malpractice risk.
Verify payer mix, contract terms, and accounts receivable quality. Confirm the practice's contracted rates, out-of-network exposure, and how much of AR is tied up in slow-paying medical-legal cases, since that affects working capital needs post-close.
Confirm the year founded, license transferability, and staff retention. Since years in business is unlisted, establish the operating history, whether key staff and mid-level providers will stay, and what credentialing and payer re-enrollment a new owner must complete to keep cash flowing.

Source

Originally listed on BusinessBroker.net. View original listing →